This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Li, S.-H. Articles by Li, X.-J. Search for Related Content PubMed PubMed Citation Articles by Li, S.-H. Articles by Li, X.-J. Social Bookmarking                   What's this?

Huntington and its Role in Neuronal Degeneration

Department of Human Genetics, School of Medicine Emory University

Xiao-Jiang Li

Department of Human Genetics, School of Medicine, Emory University, xiaoli{at}genetics.emory.edu

Huntington’s disease results from a polyglutamine expansion in the N-terminal region of huntingtin (htt). This abnormality causes protein aggregation and leads to neurotoxicity. Despite its widespread expression in the brain and body, mutant htt causes selective neurodegeneration in Huntington’s disease patient brains. However, Huntington’s disease mouse models expressing mutant htt do not have obvious neurodegeneration despite significant neurological symptoms. Most Huntington’s disease mouse models display the accumulation of toxic N-terminal mutant htt fragments in both the nucleus and neuronal processes, suggesting that these subcellular sites are hotspots for the early neuropathology of Huntington’s disease. Intranuclear htt affects gene expression and may cause neuronal dysfunction. Mutant htt in neuronal processes affects axonal transport and induces degeneration, and these effects may be more relevant to the selective neurodegeneration in Huntington’s disease. Growing evidence has also suggested that mutant htt mediates multiple pathological pathways. This review discusses the early pathological changes identified in Huntington’s disease cellular and animal models. These changes may be the causes of neurode-generation.

Key Words: Huntington • Polyglutamine • Neurodegeneration • Pathogenesis • Aggregation

The Neuroscientist, Vol. 10, No. 5, 467-475 (2004)
DOI: 10.1177/1073858404266777


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. N. Savas, A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. Shiekhattar, S. P. Markey, and N. Tanese Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies PNAS, August 5, 2008; 105(31): 10820 - 10825. [Abstract] [Full Text] [PDF]

				V. J. Davies, A. J. Hollins, M. J. Piechota, W. Yip, J. R. Davies, K. E. White, P. P. Nicols, M. E. Boulton, and M. Votruba Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function Hum. Mol. Genet., June 1, 2007; 16(11): 1307 - 1318. [Abstract] [Full Text] [PDF]

				A. Solans, A. Zambrano, M. Rodriguez, and A. Barrientos Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III Hum. Mol. Genet., October 15, 2006; 15(20): 3063 - 3081. [Abstract] [Full Text] [PDF]

				M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J. Neurosci., April 26, 2006; 26(17): 4649 - 4659. [Abstract] [Full Text] [PDF]

				A. Benchoua, Y. Trioulier, D. Zala, M.-C. Gaillard, N. Lefort, N. Dufour, F. Saudou, J.-M. Elalouf, E. Hirsch, P. Hantraye, et al. Involvement of Mitochondrial Complex II Defects in Neuronal Death Produced by N-Terminus Fragment of Mutated Huntingtin Mol. Biol. Cell, April 1, 2006; 17(4): 1652 - 1663. [Abstract] [Full Text] [PDF]

				H. Paulson RNA interference as potential therapy for neurodegenerative disease: Applications to inclusion-body myositis? Neurology, January 24, 2006; 66(1_suppl_1): S114 - S117. [Abstract] [Full Text] [PDF]

				M. Ralser, U. Nonhoff, M. Albrecht, T. Lengauer, E. E. Wanker, H. Lehrach, and S. Krobitsch Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways Hum. Mol. Genet., October 1, 2005; 14(19): 2893 - 2909. [Abstract] [Full Text] [PDF]